Abstract
The present study aimed to systematically assess acute, dose-related behavioural effects of an extract of guaraná plant for the first time in humans.
This double-blind, counterbalanced, placebo-controlled study (n = 26) assessed the acute mood and cognitive effects throughout the day of four different doses (37.5mg, 75mg, 150mg and 300mg) of a standardised guaraná extract (PC-102). Assessment included the Cognitive Drug Research computerized test battery and Bond-Lader mood scales.
Guaraná improved secondary memory performance and increased alert and content mood ratings. The two lower doses produced more positive cognitive effects than the higher doses.
This research supports previous findings of cognitive improvements following 75mg guaraná and provides the first exploration of different dose effects of guaraná in humans. The findings suggest that the effects cannot be attributed to caffeine alone.
This double-blind, counterbalanced, placebo-controlled study (n = 26) assessed the acute mood and cognitive effects throughout the day of four different doses (37.5mg, 75mg, 150mg and 300mg) of a standardised guaraná extract (PC-102). Assessment included the Cognitive Drug Research computerized test battery and Bond-Lader mood scales.
Guaraná improved secondary memory performance and increased alert and content mood ratings. The two lower doses produced more positive cognitive effects than the higher doses.
This research supports previous findings of cognitive improvements following 75mg guaraná and provides the first exploration of different dose effects of guaraná in humans. The findings suggest that the effects cannot be attributed to caffeine alone.
| Original language | English |
|---|---|
| Pages (from-to) | 65-70 |
| Journal | Journal of Psychopharmacology |
| Volume | 12 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jan 2007 |